공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 소양증 치료제 시장

Global Pruritus Therapeutics Market Research Report 2017

리서치사 QYResearch
발행일 2017년 12월 상품 코드 597664
페이지 정보 영문
가격
US $ 2,900 ₩ 3,301,000 PDF (Single User License)
US $ 5,800 ₩ 6,602,000 PDF (Enterprise Wide License)


세계의 소양증 치료제 시장 Global Pruritus Therapeutics Market Research Report 2017
발행일 : 2017년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 소양증 치료제(Pruritus Therapeutics) 시장에 대해 조사했으며, 시장 및 제품 정의와 개요, 종류·용도·지역/주요 국가별 매출 규모 추정과 예측, 시장에 대한 각종 영향요인, 경쟁 상황과 시장 점유율, 주요 제조업체 개요 등의 정보를 전해드립니다.

제1장 시장 개요

  • 제품 개요와 범위
  • 시장 분석과 예측 : 종류별
    • 매출과 성장률 비교
    • 시장 점유율
    • 코르티코스테로이드
    • 항히스타민제
    • 칼시뉴린 억제제
  • 시장 분석과 예측 : 용도별
    • 매출 비교
    • 외용약
    • 경구약
    • 주사제
  • 시장 분석과 예측 : 지역별
  • 시장 예측

제2장 경쟁 분석 : 제조업체별

  • 매출, 시장 점유율 추정
  • 총이익, 시장 점유율 추정
  • 주요 제조업체의 본사, 설립년
  • 경쟁 상황과 동향

제3장 매출 추정 : 지역별

제4장 매출 추정 : 종류별

제5장 매출 추정 : 용도별

제6장 주요 제조업체 분석

  • J&J
  • Abbott
  • Amgen
  • LEO Pharma
  • Novartis
  • Bayer
  • Pfizer
  • UCB Pharma
  • GlaxoSmithKline
  • Galderma
  • Huapont

제7장 제조 비용 분석

  • R&D 비용 분석
  • 비용 구조 분석
  • 제조 공정 분석

제8장 산업 체인, 조달 전략, 다운스트림 바이어

제9장 마케팅 전략, 유통 판매업체

제10장 시장 영향요인 분석

  • 성장 촉진요인
  • 소비자 요구와 고객 선호의 변화
  • 정치 경제 환경의 변화

제11장 시장 예측

  • 매출 예측
  • 매출 예측 : 지역별
  • 매출 예측 : 종류별
  • 매출 예측 : 용도별

제12장 조사 결과와 결론

제13장 조사 방법과 데이터 소스

KSM 18.01.09

In the last several years, global market of Pruritus Therapeutics developed smoothly, with an average growth rate of 4.8%. In 2016, global consumption value of Pruritus Therapeutics is nearly 10.8 billion USD.

This report studies Pruritus Therapeutics in Global market, especially in North America, Europe, China, Rest of Asia, focuses on top manufacturers in global market, with revenue and market share for each manufacturer, covering:

  • J&J
  • Abbott
  • Amgen
  • LEO Pharma
  • Novartis
  • Bayer
  • Pfizer
  • UCB Pharma
  • GlaxoSmithKline
  • Galderma
  • Huapont

Market Segment by Regions, this report splits Global into several key Regions, with revenue, market share and growth rate of Pruritus Therapeutics in these regions, from 2012 to 2022 (forecast), like:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Split by Product Types, with revenue market share and growth rate of each type, can be divided into:

  • Antihistamines
  • Corticosteroids
  • Calcineurin Inhibitors
  • Other

Split by applications, this report focuses on revenue market share and growth rate of Pruritus Therapeutics in each application, can be divided into:

  • External Use
  • Oral
  • Injection

Table of Contents

1. Pruritus Therapeutics Market Overview

  • 1.1. Product Overview and Scope of Pruritus Therapeutics
  • 1.2. Pruritus Therapeutics Segment by Types and Drugs Types
    • 1.2.1. Global Pruritus Therapeutics Revenue and Growth (%) Comparison by Types (2012-2022)
    • 1.2.2. Global Pruritus Therapeutics Revenue Market Share (%) by Types in 2016
    • 1.2.3. Corticosteroids
    • 1.2.4. Antihistamines
    • 1.2.5. Calcineurin Inhibitors
  • 1.3. Pruritus Therapeutics Segment by Applications
    • 1.3.1. Global Pruritus Therapeutics Revenue Comparison by Applications (2012-2022)
    • 1.3.2. External Use
    • 1.3.3. Oral
    • 1.3.4. Injection
  • 1.4. Pruritus Therapeutics Market by Regions
    • 1.4.1. Global Pruritus Therapeutics Market Size and Growth (%) Comparison by Regions
    • 1.4.2. North America Status and Prospect (2012-2022)
    • 1.4.3. Asia-Pacific Status and Prospect (2012-2022)
    • 1.4.4. Europe Status and Prospect (2012-2022)
    • 1.4.5. South America Status and Prospect (2012-2022)
    • 1.4.6. Middle East and Africa Status and Prospect (2012-2022)
  • 1.5. Global Market Size (Value) of Pruritus Therapeutics (2012-2022)

2. Global Pruritus Therapeutics Market Competition by Manufacturers

  • 2.1. Global Pruritus Therapeutics Revenue and Share by Manufacturers (2016 and 2017)
  • 2.2. Global Pruritus Therapeutics Gross Profit and Share by Manufacturers (2016 and 2017)
  • 2.3. Global Pruritus Therapeutics Gross Margin of Manufacturers (2016 and 2017)
  • 2.4. Manufacturers Pruritus Therapeutics Headquarters, Founded Time
  • 2.5. Pruritus Therapeutics Market Competitive Situation and Trends
    • 2.5.1. Pruritus Therapeutics Market Concentration Rate
    • 2.5.2. Pruritus Therapeutics Market Share of Top 3 and Top 5 Manufacturers
    • 2.5.3. Mergers. Acquisitions, Expansion

3. Global Pruritus Therapeutics Revenue (Value) by Regions (2012-2017)

  • 3.1. Global Pruritus Therapeutics Revenue (Value) and Market Share by Regions (2012-2017)
  • 3.2. Global Pruritus Therapeutics Gross Profit and Market Share by Regions (2012-2017)
  • 3.3. Global Pruritus Therapeutics Revenue and Gross Margin (2012-2017)
  • 3.4. North America Pruritus Therapeutics Revenue and Gross Margin (2012-2017)
  • 3.5. Europe Pruritus Therapeutics Revenue and Gross Margin (2012-2017)
  • 3.6. Asia-Pacific Pruritus Therapeutics Revenue and Gross Margin (2012-2017)
  • 3.7. South America Pruritus Therapeutics Revenue and Gross Margin (2012-2017)
  • 3.8. Middle East and Africa Pruritus Therapeutics Revenue and Gross Margin (2012-2017)

4. Global Pruritus Therapeutics Revenue Trend by Type

  • 4.1. Global Pruritus Therapeutics Revenue and Market Share by Product Catalog (2012-2017)
  • 4.2. Global Pruritus Therapeutics Revenue Growth by Type (2012-2017)

5. Global Pruritus Therapeutics Market Analysis by Applications

  • 5.1. Global Pruritus Therapeutics Revenue and Market Share by Applications (2012-2017)
  • 5.2. Global Pruritus Therapeutics Revenue Growth Rate (%) by Applications (2012-2017)

6. Analysis of Pruritus Therapeutics Industry Key Manufacturers

  • 6.1. J&J
    • 6.1.1. Company Profile
    • 6.1.2. Product Information
    • 6.1.3. Revenue, Gross Profit and Gross Margin
  • 6.2. Abbott
    • 6.2.1. Company Profile
    • 6.2.2. Product Information
    • 6.2.3. Revenue, Gross Profit and Gross Margin
  • 6.3. Amgen
    • 6.3.1. Company Profile
    • 6.3.2. Product Information
    • 6.3.3. Revenue, Gross Profit and Gross Margin
  • 6.4. LEO Pharma
    • 6.4.1. Company Profile
    • 6.4.2. Product Information
    • 6.4.3. Revenue, Gross Profit and Gross Margin
  • 6.5. Novartis
    • 6.5.1. Company Profile
    • 6.5.2. Product Information
    • 6.5.3. Revenue, Gross Profit and Gross Margin
  • 6.6. Bayer
    • 6.6.1. Company Profile
    • 6.6.2. Product Information
    • 6.6.3. Revenue, Gross Profit and Gross Margin
  • 6.7. Pfizer
    • 6.7.1. Company Profile
    • 6.7.2. Product Information
    • 6.7.3. Revenue, Gross Profit and Gross Margin
  • 6.8. UCB Pharma
    • 6.8.1. Company Profile
    • 6.8.2. Product Information
    • 6.8.3. Revenue, Gross Profit and Gross Margin
  • 6.9. GlaxoSmithKline
    • 6.9.1. Company Profile
    • 6.9.2. Product Information
    • 6.9.3. Revenue, Gross Profit and Gross Margin
  • 6.10. Galderma
    • 6.10.1. Company Profile
    • 6.10.2. Product Information
    • 6.10.3. Revenue, Gross Profit and Gross Margin
  • 6.11. Huapont
    • 6.11.1. Company Profile
    • 6.11.2. Product Information
    • 6.11.3. Revenue, Gross Profit and Gross Margin

7. Pruritus Therapeutics Manufacturing Cost Analysis

  • 7.1. Pruritus Therapeutics R&D Cost Analysis
    • 7.1.1. Clinical Phase Costs
    • 7.1.2. Capitalized Costs
  • 7.2. Proportion of Manufacturing Cost Structure
    • 7.2.1. Raw Materials
    • 7.2.2. Labor Cost
    • 7.2.3. Manufacturing Expenses
    • 7.2.4. Other Costs Analysis
  • 7.3. Manufacturing Process Analysis of Pruritus Therapeutics

8. Industrial Chain, Sourcing Strategy and Downstream Buyers

  • 8.1. Pruritus Therapeutics Industrial Chain Analysis
  • 8.2. Upstream Raw Materials Sourcing
  • 8.3. Downstream Buyers

9. Marketing Strategy Analysis, Distributors/Traders

  • 9.1. Marketing Channel
    • 9.1.1. Direct Marketing
    • 9.1.2. Indirect Marketing
    • 9.1.3. Marketing Channel Development Trend
  • 9.2. Market Positioning
    • 9.2.1. Pricing Strategy
    • 9.2.2. Brand Strategy
  • 9.3. Distributors/Traders List

10. Market Effect Factors Analysis

  • 10.1. Market Drivers
  • 10.2. Consumer Needs/Customer Preference Change
  • 10.3. Economic/Political Environmental Change

11. Global Pruritus Therapeutics Market Forecast (2017-2022)

  • 11.1. Global Pruritus Therapeutics Revenue Forecast (2017-2022)
  • 11.2. Global Pruritus Therapeutics Revenue Forecast by Regions (2017-2022)
    • 11.2.1. North America Pruritus Therapeutics Revenue Forecast (2017-2022)
    • 11.2.2. Europe Pruritus Therapeutics and Revenue Forecast (2017-2022)
    • 11.2.3. Asia-Pacific Pruritus Therapeutics Revenue Forecast (2017-2022)
    • 11.2.4. South America Pruritus Therapeutics Revenue Forecast (2017-2022)
    • 11.2.5. Middle East and Africa Pruritus Therapeutics Revenue Forecast (2017-2022)
  • 11.3. Global Pruritus Therapeutics Revenue Forecast by Type (2017-2022)
  • 11.4. Global Pruritus Therapeutics Revenue Forecast by Application (2017-2022)

12. Research Findings and Conclusion

13. Methodology and Data Source

  • 13.1. Methodology/Research Approach
    • 13.1.1. Research Programs/Design
    • 13.1.2. Market Size Estimation
    • 13.1.3. Market Breakdown and Data Triangulation
  • 13.2. Data Source
    • 13.2.1. Secondary Sources
    • 13.2.2. Primary Sources
  • 13.3. Disclaimer
  • 13.4. Author List

List of Tables and Figures

  • Figure Picture of Pruritus Therapeutics
  • Table Global Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
  • Figure Global Revenue Market Share of Pruritus Therapeutics by Types in 2016
  • Figure Product Picture of Corticosteroids
  • Figure Product Picture of Antihistamines
  • Figure Product Picture of Calcineurin Inhibitors
  • Table Global Pruritus Therapeutics Revenue (M USD) Comparison by Applications (2012-2022)
  • Figure Pruritus Therapeutics Revenue Market Share by Applications in 2016
  • Figure External Use Examples
  • Figure Oral Examples
  • Figure Injection Examples
  • Table Global Market Pruritus Therapeutics Revenue (M USD) Comparison by Regions 2012-2022
  • Figure North America Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
  • Figure Asia-Pacific Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
  • Figure Europe Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
  • Figure South America Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
  • Figure Middle East and Africa Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
  • Figure Global Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
  • Table Global Pruritus Therapeutics Revenue (M USD) by Manufacturers (2016 and 2017)
  • Table Global Pruritus Therapeutics Revenue Share by Manufacturers (2016 and 2017)
  • Figure 2016 Global Pruritus Therapeutics Revenue Share by Manufacturers
  • Figure 2017 Global Pruritus Therapeutics Revenue Share by Manufacturers
  • Table Global Pruritus Therapeutics Gross Profit (M USD) of Key Manufacturers (2016 and 2017)
  • Table Global Pruritus Therapeutics Gross Profit Share by Manufacturers (2016 and 2017)
  • Figure 2016 Pruritus Therapeutics Gross Profit Share by Manufacturers
  • Figure 2017 Pruritus Therapeutics Gross Profit Share by Manufacturers
  • Table Global Market Pruritus Therapeutics Gross Margin of Key Manufacturers (2016 and 2017)
  • Figure Global Market Pruritus Therapeutics Gross Margin of Key Manufacturers in 2016
  • Figure Global Market Pruritus Therapeutics Gross Margin of Key Manufacturers in 2017
  • Table Manufacturers Pruritus Therapeutics Headquarters and Founded Time
  • Figure Pruritus Therapeutics Revenue Market Concentration Rate in 2016
  • Figure Pruritus Therapeutics Revenue Market Share of Top 3 Manufacturers in 2016
  • Figure Pruritus Therapeutics Revenue Market Share of Top 5 Manufacturers in 2016
  • Table Mergers & Acquisitions, Expansion
  • Table Global Pruritus Therapeutics Revenue (M USD) by Regions (2012-2017)
  • Table Global Pruritus Therapeutics Revenue Market Share by Regions (2012-2017)
  • Figure 2012-2017 Global Pruritus Therapeutics Revenue Market Share by Regions
  • Table 2016 Global Pruritus Therapeutics Revenue Market Share by Regions
  • Table Global Pruritus Therapeutics Gross Profit (M USD) by Regions (2012-2017)
  • Figure Global Pruritus Therapeutics Gross Profit and Market Share by Regions (2012-2017)
  • Figure 2012-2017 Global Pruritus Therapeutics Gross Profit Market Share by Regions
  • Table 2016 Global Pruritus Therapeutics Gross Profit Market Share by Regions
  • Table Global Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
  • Table North America Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
  • Table Europe Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
  • Table Asia-Pacific Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
  • Table South America Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
  • Table Middle East and Africa Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
  • Table Global Pruritus Therapeutics Revenue (M USD) by Product Catalog (2012-2017)
  • Table Global Pruritus Therapeutics Revenue Share (%) by Product Catalog (2012-2017)
  • Figure Revenue Market Share (%) of Pruritus Therapeutics by Product Catalog (2012-2017)
  • Figure 2016 Revenue Market Share (%) of Pruritus Therapeutics by Product Catalog
  • Figure Global Pruritus Therapeutics Revenue Growth (%) by Type (2012-2017)
  • Table Global Pruritus Therapeutics Revenue (M USD) by Applications (2012-2017)
  • Table Global Pruritus Therapeutics Revenue Market Share (%) by Applications (2012-2017)
  • Figure Global Pruritus Therapeutics Revenue Market Share (%) by Applications (2012-2017)
  • Figure Global Pruritus Therapeutics Revenue Market Share (%) by Applications in 2016
  • Table Global Pruritus Therapeutics Revenue Growth Rate (%) by Applications (2012-2017)
  • Figure Global Pruritus Therapeutics Revenue Growth Rate (%) by Applications (2012-2017)
  • Table J&J Company Profile
  • Figure Pruritus Therapeutics Product Introduction of J&J
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of J&J 2016-2017
  • Table Abbott Company Profile
  • Figure Pruritus Therapeutics Product Introduction of Abbott
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Abbott 2016-2017
  • Table Amgen Company Profile
  • Figure Pruritus Therapeutics Product Introduction of Amgen
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Amgen 2016-2017
  • Table LEO Pharma Company Profile
  • Figure Pruritus Therapeutics Product Introduction of LEO Pharma
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of LEO Pharma 2016-2017
  • Table Novartis Company Profile
  • Figure Pruritus Therapeutics Product Introduction of Novartis
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Novartis 2016-2017
  • Table Bayer Company Profile
  • Figure Pruritus Therapeutics Product Introduction of Bayer
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Bayer 2016-2017
  • Table Pfizer Company Profile
  • Figure Pruritus Therapeutics Product Introduction of Pfizer
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Pfizer 2016-2017
  • Table UCB Pharma Company Profile
  • Figure Pruritus Therapeutics Product Introduction of UCB Pharma
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of UCB Pharma 2016-2017
  • Table GlaxoSmithKline Company Profile
  • Figure Pruritus Therapeutics Product Introduction of GlaxoSmithKline
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of GlaxoSmithKline 2016-2017
  • Table Galderma Company Profile
  • Figure Pruritus Therapeutics Product Introduction of Galderma
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Galderma 2016-2017
  • Table Huapont Company Profile
  • Figure Pruritus Therapeutics Product Introduction of Huapont
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Huapont 2016-2017
  • Figure Typical Phases from Research to the Market for a Drug Candidate
  • Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Pruritus Therapeutics Compound
  • Table Capitalized Preclinical and Clinical Period Costs per Investigational Pruritus Therapeutics Compound
  • Table Manufacturing Cost Structure of Pruritus Therapeutics
  • Figure Brazil Overview of Average Monthly Wages 2015-2016 (BRL/Month)
  • Figure Argentina Overview of Average Monthly Wages 2012-2016 (ARS/Month)
  • Figure Mexico Overview of Average Monthly Wages 2012-2016(MXN/Day)
  • Figure USA Labor Cost Analysis
  • Figure Cost of Employing a Factory Worker
  • Figure 2016 Estimated Labour Costs for the Whole Economy in EuropeR
  • Figure Monthly Minimum Wages in Asia 2016
  • Figure China Labor Costs
  • Table Average Price of Electricity to Ultimate Customers
  • Figure Electricity Prices for Household Consumers in 2016
  • Figure Summary of the Driving Assumptions
  • Figure Industrial Electric Rates 2016 (PER KWH)
  • Figure Manufacturing Process Analysis of Pruritus Therapeutics
  • Figure Pruritus Therapeutics Industrial Chain Analysis
  • Table Major Buyers of Pruritus Therapeutics
  • Figure Marketing Channel for Pruritus Therapeutics
  • Table Distributors/Traders List
  • Table Market Drivers of Pruritus Therapeutics
  • Figure Global GDP Growth Rate for 2015
  • Figure US GDP 2006-2016 (Billion USD)
  • Figure US CPI Change 2016-2017
  • Figure EU GDP 2006-2016 (Billion USD)
  • Figure EU CPI Change 2012-2016
  • Figure Germany GDP 2006-2016 (Billion USD)
  • Figure Germany CPI Change 2016-2017
  • Figure UK GDP 2006-2016 (Billion USD)
  • Figure UK CPI Change 2016-2017
  • Figure Italy GDP 2006-2016 (Billion USD)
  • Figure Italy CPI Change 2016-2017
  • Figure Japan GDP 2006-2016 (Billion USD)
  • Figure Japan CPI Change 2012-2016
  • Figure China GDP 2006-2016 (Billion USD)
  • Figure China CPI Change 2016-2017
  • Figure Global Pruritus Therapeutics Revenue (M USD) and Growth Rate Forecast (2017-2022)
  • Table Global Pruritus Therapeutics Revenue (M USD) Forecast by Regions (2017-2022)
  • Figure Global Pruritus Therapeutics Revenue Forecast by Regions (2017-2022)
  • Figure North America Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
  • Figure Europe Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
  • Figure Asia-Pacific Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
  • Figure South America Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
  • Figure Middle East and Africa Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
  • Table Global Pruritus Therapeutics Revenue (M USD) Forecast by Product Catalog (2017-2022)
  • Figure Global Pruritus Therapeutics Revenue Market Share (%) Forecast by Product Catalog (2017-2022)
  • Table Global Pruritus Therapeutics Revenue (M USD) Forecast by Application (2017-2022)
  • Figure Global Pruritus Therapeutics Revenue Forecast by Application (2017-2022)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top
전화 문의
F A Q